Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN).

Li-Xin GuoLi LiQiurong YuNa WangJun ChenZhiquan WangYuchen Ding

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

The present analysis revealed real-world baseline characteristics of patients with T2DM in China who use dulaglutide enrolled in TRUST-CHN. These data will enable further exploration of the characteristics of patients with T2DM in China and provide an insight on the current use of dulaglutide in clinical practice.

Keyphrases

clinical practice
health information
healthcare
metabolic syndrome
glycemic control
big data
skeletal muscle
machine learning
insulin resistance
artificial intelligence